申请人:SmithKline Beecham Corporation
公开号:US06780869B1
公开(公告)日:2004-08-24
The invention provides the compounds of formula (I)
and pharmaceutically acceptable derivatives thereof, in which:
R1 and R2 are independently selected from H, C1-6 alkyl, C2-6alkenyl, C3-6alkynyl, C3-10cycloalkylC0-6alkyl or C4-12bridged cycloalkane; and R3 is C1-6alkyl or NH2.
Compounds of formula (I) are potent and selective inhibitors of COX-2 and are of use in the treatment of pain, fever, inflammation and a variety of conditions and diseases.
该发明提供了式(I)的化合物及其药学上可接受的衍生物,其中:R1和R2分别选自H、C1-6烷基、C2-6烯基、C3-6炔基、C3-10环烷基C0-6烷基或C4-12桥环烷烃;R3为C1-6烷基或NH2。式(I)的化合物是COX-2的有效选择性抑制剂,并可用于治疗疼痛、发热、炎症和各种疾病和病症。